Aquestive Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AQUESTIVE, and when can generic versions of AQUESTIVE drugs launch?
AQUESTIVE has three approved drugs.
There are five US patents protecting AQUESTIVE drugs. There is one tentative approval on AQUESTIVE drugs.
There are one hundred and ninety-three patent family members on AQUESTIVE drugs in twenty-three countries.
Summary for Aquestive
| International Patents: | 193 |
| US Patents: | 5 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Aquestive: | See patent lawsuits for Aquestive |
| PTAB Cases with Aquestive as petitioner: | See PTAB cases with Aquestive as petitioner |
Drugs and US Patents for Aquestive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-001 | Jul 2, 2010 | DISCN | Yes | No | 9,095,577 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | DISCN | Yes | No | 8,765,167 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | DISCN | Yes | No | 8,580,830 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Aquestive | ZUPLENZ | ondansetron | FILM;ORAL | 022524-002 | Jul 2, 2010 | DISCN | Yes | No | 9,095,577 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aquestive
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | 8,603,514 | ⤷ Sign Up |
| Aquestive | EXSERVAN | riluzole | FILM;ORAL | 212640-001 | Nov 22, 2019 | 8,765,167 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Aquestive Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
